132 related articles for article (PubMed ID: 7769237)
1. Re-evaluation of the storage conditions for blood samples which are used for determination of complement activation.
Stöve S; Klos A; Bautsch W; Köhl J
J Immunol Methods; 1995 May; 182(1):1-5. PubMed ID: 7769237
[TBL] [Abstract][Full Text] [Related]
2. Angiography and complement activation. Evidence for generation of C3a anaphylatoxin by intravascular contrast agents.
Westaby S; Dawson P; Turner MW; Pridie RB
Cardiovasc Res; 1985 Feb; 19(2):85-8. PubMed ID: 3872180
[TBL] [Abstract][Full Text] [Related]
3. Complement activation during storage of whole blood, red cells, plasma, and buffy coat.
Hyllner M; Arnestad JP; Bengtson JP; Rydberg L; Bengtsson A
Transfusion; 1997 Mar; 37(3):264-8. PubMed ID: 9122898
[TBL] [Abstract][Full Text] [Related]
4. Complement activation products in liquid stored plasma and C3a kinetics after transfusion of autologous plasma.
Norda R; Schött U; Berséus O; Akerblom O; Nilsson B; Ekdahl KN; Stegmayr BG; Knutson F
Vox Sang; 2012 Feb; 102(2):125-33. PubMed ID: 21770955
[TBL] [Abstract][Full Text] [Related]
5. [Complement activation during storage of preserved blood].
Schleunig M; Schmid-Haslbeck M; Wimmer R; Mempel W
Beitr Infusionsther; 1990; 26():81-5. PubMed ID: 1703907
[TBL] [Abstract][Full Text] [Related]
6. Anaphylatoxins in fresh-frozen plasma.
Sonntag J; Stiller B; Walka MM; Maier RF
Transfusion; 1997 Aug; 37(8):798-803. PubMed ID: 9280323
[TBL] [Abstract][Full Text] [Related]
7. Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis. Correlation with severity of disease.
Gardinali M; Padalino P; Vesconi S; Calcagno A; Ciappellano S; Conciato L; Chiara O; Agostoni A; Nespoli A
Arch Surg; 1992 Oct; 127(10):1219-24. PubMed ID: 1417490
[TBL] [Abstract][Full Text] [Related]
8. Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis.
Hack CE; Nuijens JH; Felt-Bersma RJ; Schreuder WO; Eerenberg-Belmer AJ; Paardekooper J; Bronsveld W; Thijs LG
Am J Med; 1989 Jan; 86(1):20-6. PubMed ID: 2783358
[TBL] [Abstract][Full Text] [Related]
9. Possible mechanism for in vitro complement activation in blood and plasma samples: futhan/EDTA controls in vitro complement activation.
Pfeifer PH; Kawahara MS; Hugli TE
Clin Chem; 1999 Aug; 45(8 Pt 1):1190-9. PubMed ID: 10430784
[TBL] [Abstract][Full Text] [Related]
10. Effects of leukocyte depletion on the formation of anaphylatoxins in stored whole blood.
Schleuning M; Utz H; Heim M; Mempel W
Infusionsther Transfusionsmed; 1992 Oct; 19(5):242-4. PubMed ID: 1288768
[TBL] [Abstract][Full Text] [Related]
11. Anaphylatoxin generation and distribution during in vitro LDL apheresis.
Parusel M; Kadar JG; Borberg H
Infusionsther Transfusionsmed; 1992 Oct; 19(5):245-8. PubMed ID: 1288769
[TBL] [Abstract][Full Text] [Related]
12. A screening test for modified hemoglobin blood substitutes before clinical use: based on C3a complement activation in human plasma.
Chang TM; Lister C
Biomater Artif Cells Artif Organs; 1990; 18(5):693-701. PubMed ID: 2099226
[TBL] [Abstract][Full Text] [Related]
13. Complement activation produced by biomaterials.
Chenoweth DE
Artif Organs; 1988 Dec; 12(6):508-10. PubMed ID: 3265053
[TBL] [Abstract][Full Text] [Related]
14. Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome.
Stöve S; Welte T; Wagner TO; Kola A; Klos A; Bautsch W; Köhl J
Clin Diagn Lab Immunol; 1996 Mar; 3(2):175-83. PubMed ID: 8991632
[TBL] [Abstract][Full Text] [Related]
15. The ischaemic leg as a source of complement activation.
Bengtson A; Holmberg P; Heideman M
Br J Surg; 1987 Aug; 74(8):697-700. PubMed ID: 3498527
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunoassay for anaphylatoxins: a sensitive method for determining complement activation products in biological fluids.
Wagner JL; Hugli TE
Anal Biochem; 1984 Jan; 136(1):75-88. PubMed ID: 6711816
[TBL] [Abstract][Full Text] [Related]
17. Anaphylatoxin generation in multisystem organ failure.
Heideman M; Hugli TE
J Trauma; 1984 Dec; 24(12):1038-43. PubMed ID: 6334754
[TBL] [Abstract][Full Text] [Related]
18. Complement activation and generation of C3a anaphylatoxin by radiological contrast agents.
Dawson P; Turner MW; Bradshaw A; Westaby S
Br J Radiol; 1983 Jul; 56(667):447-8. PubMed ID: 6602640
[TBL] [Abstract][Full Text] [Related]
19. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
Sergeev IuV; Reznikov IuP; Lobanova EV; Pimenova NS
Vestn Dermatol Venerol; 1989; (4):4-7. PubMed ID: 2788339
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis.
Hopkins P; Belmont HM; Buyon J; Philips M; Weissmann G; Abramson SB
Arthritis Rheum; 1988 May; 31(5):632-41. PubMed ID: 3259882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
